Top Markets
#1 Black Phoenix Black Phoenix +860.29%
#2 QuantixAI QuantixAI +102.63%
#3 MetaDAO MetaDAO +26.72%
#4 Pons Pons +23.08%
#5 LayerZero LayerZero +20.52%
#6 Ontology Gas Ontology Gas +19.80%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +19.11%
#8 Bedrock Bedrock +18.57%
#9 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +18.04%
#10 SPX6900 SPX6900 +15.41%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Immunovant, Inc. Immunovant, Inc.

Immunovant, Inc.

IMVT
Rank in Stocks #2339
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase,... Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in certain autoimmune diseases. Batoclimab is currently undergoing Phase IIa clinical evaluations for treating both myasthenia gravis and thyroid eye disease. Additionally, it has commenced Phase II clinical studies for patients suffering from warm autoimmune hemolytic anemia. Established in 2018, Immunovant operates from its headquarters in New York, New York, functioning as a subsidiary under the umbrella of Roivant Sciences Ltd.
Share Price
$43.48
Market Cap
$8.97B
Change (1 day)
0.37%
Change (1 year)
192.01%
Country
US
Trade Immunovant, Inc. (IMVT)

Category

Healthcare
Earnings for Immunovant, Inc. (IMVT)
Earnings in 2026 TTM: 0
According to Immunovant, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Immunovant, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH